Navigating The Regulatory Complexities Of Targeted Medicines In Oncology

Navigating the regulatory complexities of targeted medicines requires an in-depth understanding of the unique challenges in non-clinical and clinical development. With the targeted medicines landscape continuously evolving, it is crucial for life sciences companies to align their regulatory and clinical strategies with their business objectives. This webinar, moderated by Chris Englerth, our Director of Global Consulting Services, and featuring Christian Schneider, MD, our Chief Medical Officer, explores the strategic considerations for successfully developing a targeted medicine.

Discover the key clinical development considerations and the challenges in translational medicine for non-clinical development.